We review your medical history, current medications, and goals, and we only prescribe semaglutide when it is appropriate for you
You should use it only if your healthcare provider prescribes it after a medical evaluation
Semaglutide Not Associated with Increased Risk of Eye Disorders, 19 August 2025, The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION), 27 June 2025, WHO, PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy, 06 June 2025, European Medicine Agency, Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan, does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy
What we know about glycine: Peer-reviewed research confirms that glycine activates mTORC1 signaling, protects muscle cells from wasting, accelerates fat loss during caloric restriction, and has anti-inflammatory properties
GIP-agonism has no effect on cardiac ischemia, despite stimulating hormone-sensitive lipase phosphorylation and fatty acid oxidation, supporting the cardiac safety of GIP receptor agonism (RA) for use in multi-receptor agonism
It works best for individuals who seek steady, sustainable improvements in appetite control and digestion, rather than extreme, rapid results